Spin up a dedicated OpenClaw assistant in under two minutes—no servers, SSH, or config files. Choose your favorite LLM, connect Telegram, and you're live; $100/month includes $50 in AI credits. Stop wrangling infra and start shipping assistants today—launch now at NITROCLAW.COM.

NITROCLAW - YOUR OWN OPENCLAW ASSISTANT, ZERO SERVER HASSLE

<div>Stop wrestling with servers, SSH, and config files just to run an AI assistant. NitroClaw is a managed&nbsp;hosting platform that deploys a dedicated OpenClaw instance for you - pick your LLM, connect&nbsp;Telegram, and you're live.</div>For $100/month with $50 in AI credits included, you get a fully isolated server, automatic updates,&nbsp;99.9% uptime, and support for OpenAI, Anthropic, Google, or any OpenAI-compatible model.<div> Whether you're a power user who wants a personal AI workflow, a team lead setting up a shared&nbsp;assistant, or just someone who wants ChatGPT-level AI on Telegram without the hassle - NitroClaw&nbsp;handles the infrastructure so you don't have to.</div>You don't just get an AI assistant with NitroClaw - you get one that's always on, always yours, and&nbsp;always managed.

Your Own OpenClaw AI Assistant - Live in 2 Minutes

NitroClaw Logo

The article discusses the implications of President Trump's decision to reschedule marijuana and the subsequent steps in regulatory and legislative processes. It explores how this decision impacts the cannabis industry, potentially leading to increased research opportunities and changes in federal policy. Stakeholders in the industry express optimism about the shift, which may pave the way for more robust economic activity and state-level legislative initiatives. Experts anticipate a ripple effect in U.S. states' approaches to marijuana regulation, influencing both legal frameworks and market dynamics. The article also touches on the importance of advocacy efforts to ensure the comprehensive integration of marijuana policy changes in future legislative sessions.

Plant-touching cannabis companies would benefit from marijuana rescheduling, but it ' s one step on a longer reform road. What s next after President Trump reschedules marijuana? Is a post from: MJBizDaily: Financial, Legal &amp; Cannabusiness news for cannabis entrepreneurs

What’s next after President Trump reschedules marijuana?

The article discusses the potential rescheduling of marijuana by the Trump administration. President Trump is reportedly considering a change in how marijuana is classified, which could have significant implications for the industry. The rescheduling would move marijuana from a Schedule I drug to a less restrictive category. This change could influence federal policies and regulations surrounding marijuana businesses. The decision is part of broader discussions regarding drug policy reform in the United States.

President Donald Trump is expected to issue an executive order reclassifying cannabis under federal law, the Washington Post reported on Thursday. Report: President Trump close to marijuana rescheduling is a post from: MJBizDaily: Financial, Legal &amp; Cannabusiness news for cannabis entrepreneurs

Report: President Trump close to marijuana rescheduling

The state of Georgia is facing increased pressure to expand its low-THC medical cannabis program by 2026, amid growing demand and regulatory challenges. Stakeholders, including industry advocates and patients, are advocating for legislative changes to increase accessibility and production capacity. Current regulations restrict the number of licenses, limiting patient access and industry growth. These limitations are prompting calls for a more robust regulatory framework to support market needs. The proposed expansion could also open new opportunities for businesses and improve the state's competitive position in the cannabis industry.

Limited to low-THC oil for now, state lawmakers are under pressure to expand the Georgia medical cannabis program. Georgia under pressure to expand low-THC medical cannabis in 2026 is a post from: MJBizDaily: Financial, Legal &amp; Cannabusiness news for cannabis entrepreneurs

Georgia under pressure to expand low-THC medical cannabis in 2026

The article discusses the potential closure of Connecticut's sole medical marijuana dispensary, placing emphasis on the challenges faced by the state's cannabis market amidst shifting supplier dynamics. The dispensary's closure is attributed to financial difficulties and an inability to compete with emerging adult-use cannabis establishments. Industry experts highlight the implications for patient access and the broader business environment for medical marijuana in the region. The development signals a need to reassess business strategies to adapt to a rapidly evolving cannabis industry landscape. As Connecticut navigates this transition, stakeholders are encouraged to explore alternative paths for sustaining medical cannabis services.

Bluepoint Wellness’s move comes after repeated denials from Westport’s Planning and Zoning Commission to allow recreational cannabis sales. Connecticut’s only medical marijuana dispensary may close is a post from: MJBizDaily: Financial, Legal &amp; Cannabusiness news for cannabis entrepreneurs

Connecticut’s only medical marijuana dispensary may close

A recent regulation banning intoxicating hemp products highlights the hemp industry's ongoing struggle to establish robust and credible standards for CBD. The article discusses the implications of the ban and the need for stricter regulatory frameworks. It points to the sector's failure to align on effective standards, potentially hindering growth and consumer confidence. The piece suggests significant consequences for businesses and underscores the importance of unified guidelines. This development is critical in shaping future legislative actions impacting the CBD market.

The drumbeat has started as U. S. Stakeholders and lawmakers push back in the wake of a ban on intoxicating hemp products set to take effect at the end of this []

Intoxicating hemp ban exposes sector’s failure to define credible standards for CBD

The article discusses the strategic focus of Joe Bayern's cannabis company, which emphasizes building strong brands over expanding cultivation capacity. Bayern advocates for leveraging existing production facilities and investing in marketing to enhance brand value. This approach is aimed at differentiating in a competitive market where overproduction has been a challenge. The strategy reflects a broader industry trend of prioritizing brand identity over sheer volume in cannabis operations. Insights from this strategic shift offer a glimpse into evolving business opportunities within the sector.

Bayern will use a “culmination " of his experience to lead MM Brands as federal cannabis rescheduling unfolds. Joe Bayern s  Day 2 cannabis strategy: Build brands, not canopies is a post from: MJBizDaily: Financial, Legal &amp; Cannabusiness news for cannabis entrepreneurs

Joe Bayern’s ‘Day 2’ cannabis strategy: Build brands, not canopies

Thailand’s hemp sector appears to be quietly approaching its end, not because the crop failed, but because the industry was never taken seriously. The political retreat from cannabis now underway []

Promise of hemp in Thailand headed for collapse under politics and regulatory retreat

Hemp Trends & Shifts: What's Next for Missouri?

The latest issue of the MO Hemp News Update delves into significant developments within the cannabis and hemp industries. Notably, it explores President Trump's decision to reschedule marijuana, a move poised to reshape regulatory and legislative landscapes, encouraging research opportunities and state-level legislative initiatives. This change reflects a broader trend in drug policy reform and could substantially impact the cannabis industry. In Georgia, there is mounting pressure to expand the low-THC medical cannabis program by 2026, highlighting ongoing regulatory challenges and the demand for increased accessibility. Meanwhile, Connecticut faces the potential closure of its sole medical marijuana dispensary, prompting discussions on adapting business strategies in a shifting market. Additionally, the intoxicating hemp ban underscores the industry's struggle to establish credible standards for CBD, impacting growth and consumer confidence. Among these stories, Joe Bayern's innovative 'Day 2' strategy focuses on brand building over cultivation, reflecting a market trend toward prioritizing brand identity. These articles collectively paint a picture of an evolving industry in the midst of significant regulatory and strategic transformations.

MO Hemp News Update covers key shifts in the cannabis industry, including Trump's marijuana rescheduling impact and Georgia's push for expanded medical cannabis. It highlights Connecticut's dispensary challenges and hemp industry's struggle with CBD standards. Bayern's 'Day 2' strategy on brand focus adds insight into industry trends.

Issue %%issue_number%%

I'm curating this article for a newsletter, give me a 5 sentence summary of this article so I can copy and paste it in my newsletter.  Make the tone professional and concise.

The MO Hemp News Update provides essential updates on Missouri's hemp industry, covering legislative, market, and innovation news both locally and nationally.